News
Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...
Pharmaceutical Technology on MSN19h
RFK Jr’s mRNA funding halt signals “shift in US public health”The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback